Cargando…
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules
BACKGROUND: Myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) are two of the major players involved in the inhibition of anti-tumor immune response in cancer patients, leading to poor prognosis. Selective targeting of myeloid cells has therefore become an attractive th...
Autores principales: | Pinton, Laura, Magri, Sara, Masetto, Elena, Vettore, Marina, Schibuola, Ilaria, Ingangi, Vincenzo, Marigo, Ilaria, Matha, Kevin, Benoit, Jean-Pierre, Della Puppa, Alessandro, Bronte, Vincenzo, Lollo, Giovanna, Mandruzzato, Susanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026969/ https://www.ncbi.nlm.nih.gov/pubmed/32066449 http://dx.doi.org/10.1186/s12951-020-00589-3 |
Ejemplares similares
-
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
por: Peranzoni, Elisa, et al.
Publicado: (2020) -
Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatment
por: Mandruzzato, Susanna, et al.
Publicado: (2020) -
The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion
por: Pinton, Laura, et al.
Publicado: (2019) -
Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells
por: Damuzzo, Vera, et al.
Publicado: (2015) -
The immunosuppression pathway of tumor‐associated macrophages is controlled by heme oxygenase‐1 in glioblastoma patients
por: Magri, Sara, et al.
Publicado: (2022)